Thursday Apr 17
Why Everyone Wants To Work In Biotech
Companies like Celgene, Biogen Idec, and Gilead Sciences all took top spots on our list of the Best Employers in America .
Trending on the Topix Network
Tue Apr 15, 2014
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014
At 4:15 p.m. Eastern Time, Gilead's management will host a conference call to discuss the company's financial results for the first quarter 2014 and provide a general business update.
Mon Apr 14, 2014
Biotech stocks stronger than Nasdaq's latest weakness [04-14-14 12:30 PM]
Activist investor Daniel Loeb, who is fighting to win control of three board seats at Sotheby's , on Monday raised the temperature by saying the current board has failed and that its attacks on him are "false" and "misleading."
Biotech firms, investors biding time for breakthrough drugs
New York, NY, United States - Many biotech firms are now biding their time, waiting for their research projects to result in a breakthrough drug that will not only cure a once untreatable disease but could also make the company more profitable.
Sofosbuvir + simeprevir dual therapy shows high cure rates for...
A 12-week oral regimen of sofosbuvir plus simeprevir without pegylated interferon or ribavirin led to sustained virological response in 93% of genotype 1 hepatitis C patients with either absent to moderate liver fibrosis or with advanced fibrosis or cirrhosis, according to data from the COSMOS trial presented last week at the 49th EASL ... (more)
Sat Apr 12, 2014
Cost of Gilead's hepatitis C pill, Sovaldi, spurs revolt
Orlando Chavez, who works at the Berkeley Free Clinic, was cured of hepatitis C in 2005 after painful treatment and says he would have jumped on Gilead's new drug, Sovaldi, at any price.
The health and biomedical industries in Silicon Valley saw a 15.5 percent increase in profits in 2013 -- representing $4.4 billion -- but, perhaps more importantly, venture capital also began flowing after nearly five years of lean investments.
Fri Apr 11, 2014
Friday's ETF Movers: BBH, XME
In trading on Friday, the Biotech ETF is outperforming other ETFs, up about 0.4% on the day.
Drying Stimulus Tap Is Sore Spot for Tech Stocks
NEW YORK -- The drying stimulus tap rather than stretched valuations has been the trigger for recent selling in tech and biotech shares, some managers argue, claiming this makes another tech sector crash unlikely.
Gold Closes Near Three-Week High As Stocks Tumble; Oil, Biotech & Bitcoin Fall
Gold started higher this morning, boosted by the Federal Reserve's dovish remarks Wednesday, and continued to gain throughout the day as stocks slid and the Nasdaq neared its worst loss in nearly two years.
The Miami Herald
How the Dow Jones industrial average did Thursday
Biotech and Internet stocks tumbled again Thursday, and the broader market followed.
Gilead's Sovaldi Demonstrates Efficacy and Safety Among Chronic...
Gilead Sciences, Inc. today announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi 400 mg was administered for the treatment of chronic hepatitis C virus infection in patients with advanced liver disease.
Thu Apr 10, 2014
The Campbell Reporter
Biz Break: Silicon Valley tech stocks slaughtered ahead of earnings reports
Traders Kevin Lodewick, left, and Timothy Nick work on the floor of the New York Stock Exchange Thursday, April 10, 2014.
Biotech: Like Lambs to the Slaughter
The iShares Nasdaq Biotech ETF fell 5.6% to $221.89 today, while the SPDR S&P Biotechnology ETF dropped 6.5% to $129.79.
Stocks drop; Biotech takes another plunge
Stocks are sharply lower in afternoon trading as investors dump biotechnology shares and other industries that soared over the past year.
Stocks take another tumble; eBay heads lower
U.S. stock indexes were drifting lower Thursday as investors picked over a mixed batch of corporate earnings reports.
The Motley Fool
Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Bristol-Myers Squibb therapy for genotype 1b hepatitis C at the 49th Annual Meeting of the European Association for the Study of the Liver in London today.
Tue Apr 08, 2014
National Public Radio
Investors Shed Tech, Biotech Stocks
Technology and biotechnology companies, high-flying stocks over the last two years, have been beaten down the last three weeks.
Biotech Stocks to Watch as Sector Sells Off
The sharp drop in the iShares Nasdaq Biotechnology ETF in the last month erased all the gains made for the year.
Mon Apr 07, 2014
TD Ameritrade Says IMX for Mar. Up to 5.87
The S&P 500 climbed to a new record early in the month, but then took a few steps down to eventually close the month relatively flat compared to February.